9.000
+3,45%
2026-10-07
Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -70.2% | +23.0% | 2 / 3 | -10.1% | -1.12 pp | -0.97 pp | +5.2% | 0.00 | 11.55 | 135 | −10,1% | 0,6 | −70,2% | 11.55 | 16.87 | −31,5% |
| Pts | 0 | 0 | 8 | 0 | 4 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 9.000 (close price on 2026-10-07)EPS (TTM): 779,0
Financial charts
1.Revenue & growth
VND bn135Q2/26
1.Revenue & growth
VND bn135Q2/26
2.Profit & growth
VND bn0,61Q2/26
3.Profit mix (Penman)
VND bn6,42Q2/26
4.Margins & cost structure
%4.5%Q2/26
5.Returns & cash cycle
% · days6.8%Q2/26
6.Earnings quality & cash
VND bn23,9Q2/26
7.Asset structure
VND bn146Q2/26
8.Funding & debt health
VND bn · times146Q2/26
9.Revenue backlog
VND bn3,85Q2/26
10.Valuation
times · %11,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %102Q2/26
Adjusted EPS growth, latest quarter
-71.9%
Average adjusted EPS growth, 3 quarters
-33.1%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26